甘草养阴汤干预老年类风湿关节炎模型研究被《Chinese Medicine》接收

经过两年努力，甘草养阴汤干预老年类风湿关节炎模型研究在中国博士后基金资助下，研究成果被《Chinese Medicine》接收,Final Disposition：Accept。

来自编辑部的邮件：

CMED-D-22-01044R2

Gancao Nourishing-Yin Decoction Combined with Methotrexate in Treatment of Aging CIA Mice: A Study Based on DIA Proteomic Analysis

Yong Chen; Xing-wang Zhu; Wing-Fu Lai; Yong-pu Liu; Xuan-feng Xu; Li-ming Liu; Yan-juan Chen; Chuan-fu Zhang; Guang-yi Wang; Zhi-qiang Cheng; Dong-zhou Liu

Chinese Medicine

Dear Dr Liu,

I am pleased to inform you that your manuscript “Gancao Nourishing-Yin Decoction Combined with Methotrexate in Treatment of Aging CIA Mice: A Study Based on DIA Proteomic Analysis“ (CMED-D-22-01044R2) has been accepted for publication in Chinese Medicine.

Before publication, our production team will check the format of your manuscript to ensure that it conforms to the standards of the journal. They will be in touch shortly to request any necessary changes, or to confirm that none are needed.

Articles in this journal may be held for a short period of time prior to publication.If you have any concerns please contact the journal.

Any final comments from our reviewers or editors can be found, below. Please quote your manuscript number, CMED-D-22-01044R2, when inquiring about this submission.

We look forward to publishing your manuscript and I do hope you will consider Chinese Medicine again in the future.

Best wishes,

Chinese Medicine

https://cmjournal.biomedcentral.com/

Comments:

Reviewer ＃2: The manuscript has been well improved and is acceptable for publication in CHINESE MEDICINE.

甘草养阴汤治疗老年类风湿关节炎小鼠模型比单用西药有效，而中西医结合治疗，疗效最为显著。

《Chinese Medicine》简介

Chinese Medicine是一本开放获取的期刊。广泛收录中医药的各个方面内容的循证、研究和综述论文，包括但不限于与中医药相关的化学、生物学、药理学、药剂学、工程学、临床应用和社会经济学等主题。从中草药中发现新化合物；阐明中药的分子/细胞靶点和作用机制；开发现代中药给药和分子药剂学工具；评估假设驱动、合理设计的基础、临床前和临床研究的结果。

期刊的影响因子

我们通过查询Web of Science，Chinese Medicine近五年影响因子总体呈现稳定上升的趋势，影响因子分别为：1.508(2016)，1.802(2017)，2.265（2018），2.960（2019）。2020年影响因子更是突破历史最好成绩，增长势头强劲，增长达84%，一举突破5+分，取得5.455。很值得各位科研er关注一下。我们计算了下Chinese Medicine的自引率，2020年仅为8.95%。这个比例远远低于警戒线，各位小伙伴可以放心大胆地选择本刊，丝毫不用顾虑其被SCI剔除。

学科排名和中科院分区

通过Web of Science查询，我们发现在Integrative ＆ Complementary Medicine和Pharmacology ＆ Pharmacy分类中，该刊均位于JCR Q1区。同时，在29本全科医学与补充医学杂志中排列第2位；275本药学杂志中排列第50位。这都展现了该刊在本领域中不凡的影响力，各位小伙伴们可以好好关注一下！